CIITA-expressing GBM cells express very high levels of HLA-II complexes and naturally present a large repertoire of known HLA-I ligands, but most importantly, of novel HLA-II ligands derived from shared and immunogenic tumor-associated antigens (TAAs). This evidence concerns the gene CIITA and neoplasm.